View in EDS

Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.

Saved in:
Bibliographic Details
Title: Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Authors: Mortensen HR; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Populaire P; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Hoffmann L; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Moeller DS; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Appelt A; University of Leeds, Leeds, UK., Nafteux P; University Hospitals Leuven, Department of Thoracic Surgery, Belgium., Muijs CT; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Grau C; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, London, UK., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany., Defraene G; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, the Netherlands., Clarke CS; Research Dept. of Primary Care and Population Health, University College London, London, UK., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland., Korevaar EW; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Haustermans K; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Nordsmark M; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Achiam MP; Dept. Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Markar SR; Department of General Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgery, University of Oxford, Oxford, UK., Radhakrishna G; The Christie, Manchester, United Kingdom., Berbee M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Scartoni D; Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Orlandi E; National Center for Oncological Hadrontherapy (CNAO), Radiation Oncology Clinical Department, Pavia, Italy., Doyen J; Centre Antoine Lacassagne, Nice, France., Gregoire V; Centre Léon Bérard, 28 rue Laennec, Lyon 69373 Cedex 08, France., Crehange G; PSL Research University, RadiationOncology Department, Institut Curie, Paris/Orsay, France., Langendijk J; Department of Radiation Oncology, UniversityMedicalCentreGroningen, Groningen, The Netherlands., Lorgelly P; University of Auckland, Waipara Taumata Rau, Auckland, New Zealand., Blommenstein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR, The Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands., Byskov CS; Department of Oncology and Medical physics, Aarhus University Hospital, Aarhus, Denmark., Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Jensen MF; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Freixas GV; Maastro Proton Therapy, Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany.
Corporate Authors: PROTECT consortium
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109980. Date of Electronic Publication: 2023 Nov 05.
Publication Type: Clinical Trial Protocol; Letter
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37935284
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mortensen+HR%22">Mortensen HR</searchLink>; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Populaire+P%22">Populaire P</searchLink>; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hoffmann+L%22">Hoffmann L</searchLink>; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Moeller+DS%22">Moeller DS</searchLink>; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Appelt+A%22">Appelt A</searchLink>; University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Nafteux+P%22">Nafteux P</searchLink>; University Hospitals Leuven, Department of Thoracic Surgery, Belgium.<br /><searchLink fieldCode="AU" term="%22Muijs+CT%22">Muijs CT</searchLink>; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Grau+C%22">Grau C</searchLink>; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Hawkins+MA%22">Hawkins MA</searchLink>; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Troost+EGC%22">Troost EGC</searchLink>; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany.<br /><searchLink fieldCode="AU" term="%22Defraene+G%22">Defraene G</searchLink>; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Canters+R%22">Canters R</searchLink>; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Clarke+CS%22">Clarke CS</searchLink>; Research Dept. of Primary Care and Population Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Weber+DC%22">Weber DC</searchLink>; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Korevaar+EW%22">Korevaar EW</searchLink>; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Haustermans+K%22">Haustermans K</searchLink>; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Nordsmark+M%22">Nordsmark M</searchLink>; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Gebski+V%22">Gebski V</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Achiam+MP%22">Achiam MP</searchLink>; Dept. Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Markar+SR%22">Markar SR</searchLink>; Department of General Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgery, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Radhakrishna+G%22">Radhakrishna G</searchLink>; The Christie, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Berbee+M%22">Berbee M</searchLink>; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Scartoni+D%22">Scartoni D</searchLink>; Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Orlandi+E%22">Orlandi E</searchLink>; National Center for Oncological Hadrontherapy (CNAO), Radiation Oncology Clinical Department, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Doyen+J%22">Doyen J</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Gregoire+V%22">Gregoire V</searchLink>; Centre Léon Bérard, 28 rue Laennec, Lyon 69373 Cedex 08, France.<br /><searchLink fieldCode="AU" term="%22Crehange+G%22">Crehange G</searchLink>; PSL Research University, RadiationOncology Department, Institut Curie, Paris/Orsay, France.<br /><searchLink fieldCode="AU" term="%22Langendijk+J%22">Langendijk J</searchLink>; Department of Radiation Oncology, UniversityMedicalCentreGroningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lorgelly+P%22">Lorgelly P</searchLink>; University of Auckland, Waipara Taumata Rau, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Blommenstein+HM%22">Blommenstein HM</searchLink>; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR, The Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Byskov+CS%22">Byskov CS</searchLink>; Department of Oncology and Medical physics, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Ehmsen+ML%22">Ehmsen ML</searchLink>; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Jensen+MF%22">Jensen MF</searchLink>; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Freixas+GV%22">Freixas GV</searchLink>; Maastro Proton Therapy, Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bütof+R%22">Bütof R</searchLink>; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PROTECT+consortium%22">PROTECT consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228407192%22">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</searchLink> [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109980. <i>Date of Electronic Publication: </i>2023 Nov 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8407192 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0887 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201678140%22">01678140 </searchLink><i>NLM ISO Abbreviation: </i>Radiother Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37935284
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.radonc.2023.109980
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 109980
    Titles:
      – TitleFull: Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mortensen HR
      – PersonEntity:
          Name:
            NameFull: Populaire P
      – PersonEntity:
          Name:
            NameFull: Hoffmann L
      – PersonEntity:
          Name:
            NameFull: Moeller DS
      – PersonEntity:
          Name:
            NameFull: Appelt A
      – PersonEntity:
          Name:
            NameFull: Nafteux P
      – PersonEntity:
          Name:
            NameFull: Muijs CT
      – PersonEntity:
          Name:
            NameFull: Grau C
      – PersonEntity:
          Name:
            NameFull: Hawkins MA
      – PersonEntity:
          Name:
            NameFull: Troost EGC
      – PersonEntity:
          Name:
            NameFull: Defraene G
      – PersonEntity:
          Name:
            NameFull: Canters R
      – PersonEntity:
          Name:
            NameFull: Clarke CS
      – PersonEntity:
          Name:
            NameFull: Weber DC
      – PersonEntity:
          Name:
            NameFull: Korevaar EW
      – PersonEntity:
          Name:
            NameFull: Haustermans K
      – PersonEntity:
          Name:
            NameFull: Nordsmark M
      – PersonEntity:
          Name:
            NameFull: Gebski V
      – PersonEntity:
          Name:
            NameFull: Achiam MP
      – PersonEntity:
          Name:
            NameFull: Markar SR
      – PersonEntity:
          Name:
            NameFull: Radhakrishna G
      – PersonEntity:
          Name:
            NameFull: Berbee M
      – PersonEntity:
          Name:
            NameFull: Scartoni D
      – PersonEntity:
          Name:
            NameFull: Orlandi E
      – PersonEntity:
          Name:
            NameFull: Doyen J
      – PersonEntity:
          Name:
            NameFull: Gregoire V
      – PersonEntity:
          Name:
            NameFull: Crehange G
      – PersonEntity:
          Name:
            NameFull: Langendijk J
      – PersonEntity:
          Name:
            NameFull: Lorgelly P
      – PersonEntity:
          Name:
            NameFull: Blommenstein HM
      – PersonEntity:
          Name:
            NameFull: Byskov CS
      – PersonEntity:
          Name:
            NameFull: Ehmsen ML
      – PersonEntity:
          Name:
            NameFull: Jensen MF
      – PersonEntity:
          Name:
            NameFull: Freixas GV
      – PersonEntity:
          Name:
            NameFull: Bütof R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0887
          Numbering:
            – Type: volume
              Value: 190
          Titles:
            – TitleFull: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
              Type: main
ResultId 1